Check4Cancer and Early Labs launch partnership to offer early cancer detection tests

Check4Cancer has partnered with Early Labs to develop non-invasive, urine-based tests for the early detection of common cancers, including lung cancer. Early Labs has created a diagnostic platform that identifies cancer-associated volatile organic compound (VOC) signatures in urine and analyses them using artificial intelligence and machine learning. The company’s technology has already demonstrated high sensitivity…